TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CARDIOGEN-82

RUBIDIUM CHLORIDE RB-82
Approved 1989-12-29
4
Indications
--
Phase 3 Trials
1
Priority Reviews
36
Years on Market

Details

Status
Prescription
First Approved
1989-12-29
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: RUBIDIUM CHLORIDE RB-82

CARDIOGEN-82 Approval History

Loading approval history...

What CARDIOGEN-82 Treats

1 indications

CARDIOGEN-82 is approved for 1 conditions since its original approval in 1989. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Coronary Artery Disease
Source: FDA Label

CARDIOGEN-82 Boxed Warning

HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT and FAILURE TO FOLLOW THE ELUATE TESTING PROTOCOL High Level Radiation Exposure with Use of Incorrect Eluent Patients are exposed to high radiation levels when the CardioGen-82 generator is eluted with the incorrect eluent due to high strontium (Sr) 82 and Sr 85 breakthrough levels. Use only additive-free 0.9% Sodium Chloride Injection to elute the generator. If an incorrect solution is used to elute the CardioGen-82 generator: Immediate...

Drugs Similar to CARDIOGEN-82

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE AND VALSARTAN
AMLODIPINE BESYLATE
1 shared
ALEMBIC
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE
1 shared
STRIDES PHARMA INTL
Shared indications:
Coronary Artery Disease
AMMONIA N 13
AMMONIA N-13
1 shared
BIOMEDCL RES FDN
Shared indications:
Coronary Artery Disease
BRILINTA
TICAGRELOR
1 shared
AstraZeneca
Shared indications:
Coronary Artery Disease
CADUET
AMLODIPINE BESYLATE
1 shared
PHARMACIA
Shared indications:
Coronary Artery Disease
CARDIOLITE
TECHNETIUM TC-99M SESTAMIBI KIT
1 shared
LANTHEUS MEDCL
Shared indications:
Coronary Artery Disease
FLYRCADO
FLURPIRIDAZ F-18
1 shared
GE HLTHCARE
Shared indications:
Coronary Artery Disease
GADAVIST
GADOBUTROL
1 shared
Bayer
Shared indications:
Coronary Artery Disease
IODIXANOL
IODIXANOL
1 shared
HENGRUI PHARMA
Shared indications:
Coronary Artery Disease
KATERZIA
AMLODIPINE BENZOATE
1 shared
AZURITY
Shared indications:
Coronary Artery Disease
MONOKET
ISOSORBIDE MONONITRATE
1 shared
OMNIVIUM PHARMS
Shared indications:
Coronary Artery Disease
MYOVIEW
TECHNETIUM TC-99M TETROFOSMIN KIT
1 shared
MEDI-PHYSICS
Shared indications:
Coronary Artery Disease
NITRO-DUR
NITROGLYCERIN
1 shared
USPHARMA
Shared indications:
Coronary Artery Disease
NITROGLYCERIN
NITROGLYCERIN
1 shared
RUBICON RESEARCH
Shared indications:
Coronary Artery Disease
NITROLINGUAL PUMPSPRAY
NITROGLYCERIN
1 shared
POHL BOSKAMP
Shared indications:
Coronary Artery Disease
NITROMIST
NITROGLYCERIN
1 shared
EVUS
Shared indications:
Coronary Artery Disease
NORLIQVA
AMLODIPINE BESYLATE
1 shared
CMP DEV LLC
Shared indications:
Coronary Artery Disease
NORVASC
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Coronary Artery Disease
PERINDOPRIL ERBUMINE
PERINDOPRIL ERBUMINE
1 shared
Aurobindo Pharma
Shared indications:
Coronary Artery Disease
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CARDIOGEN-82 FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

CardioGen-82, used to produce Rubidium Chloride Rb 82 Injection, is indicated for positron emission tomography (PET) of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. CardioGen-82, used to produce Rubidium Chloride Rb 82 Injection, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary...

⚠️ BOXED WARNING

WARNING: HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT and FAILURE TO FOLLOW THE ELUATE TESTING PROTOCOL High Level Radiation Exposure with Use of Incorrect Eluent Patients are exposed to high radiation levels when the CardioGen-82 generator is eluted with the incorrect eluent due to hi...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.